Learn More
Enzo Life Sciences ARF inhibitory peptide (P-13) (1mg)

Supplier: Enzo Life Sciences BMLG4450001
Sequence is ADP-ribosylation factor (ARF) mARF1p (2-17) N-terminal peptide. Peptide inhibits ARF-dependent ADP-ribosylation by cholera toxin, endoplasmic reticulum to Golgi transport, intra-Golgi transport and endosome-endosome fusion in vitro at IC50=10-40 µM. Purity: ≥97%. Solubility: Soluble in water. Long Term Storage: -20°C.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.